These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6689949)

  • 1. Time course of reversibility of accelerated fibrinogen disappearance in diabetes mellitus: association with intravascular volume shifts.
    Jones RL; Jovanovic L; Forman S; Peterson CM
    Blood; 1984 Jan; 63(1):22-30. PubMed ID: 6689949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinopeptide-A in diabetes mellitus. Relation to levels of blood glucose, fibrinogen disappearance, and hemodynamic changes.
    Jones RL
    Diabetes; 1985 Sep; 34(9):836-43. PubMed ID: 4029510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced fibrinogen survival in diabetes mellitus. A reversible phenomenon.
    Jones RL; Peterson CM
    J Clin Invest; 1979 Mar; 63(3):485-93. PubMed ID: 429567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of persistent hyperglycaemia on hyperfibrinogenaemia and hyperviscosity in diabetes mellitus.
    Reid HL; Vigilance J; Wright-Pascoe RA; Choo-Kang E
    West Indian Med J; 2000 Dec; 49(4):281-4. PubMed ID: 11211535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the disappearance curve of labelled fibrinogen at the time of hyperfibrinogenemia in rabbits with acute or chronic intravascular coagulation.
    Hasegawa H; Watanabe N; Nagata H; Murao M
    Thromb Haemost; 1976 Aug; 36(1):49-59. PubMed ID: 1036828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of 125I-fibrinogen kinetics and fibrinopeptide A in patients with disseminated neoplasias.
    Mombelli G; Roux A; Haeberli A; Straub PW
    Blood; 1982 Aug; 60(2):381-8. PubMed ID: 7093524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinocoagulopathy in maturity onset diabetes mellitus and atherosclerosis.
    Banerjee RN; Sahni AL; Kumar V
    Thromb Diath Haemorrh; 1973 Sep; 30(1):123-32. PubMed ID: 4788739
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma disappearance and distribution volume of polyfructosan in type 1 (insulin-dependent) diabetes mellitus.
    Bent-Hansen L
    Diabetes Res; 1994; 25(3):121-8. PubMed ID: 7671551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood coagulation changes in mice bearing Lewis lung carcinoma, a metastasizing tumor.
    Poggi A; Polentarutti N; Benedetta Donati M; de Gaetano G; Garattini S
    Cancer Res; 1977 Jan; 37(1):272-7. PubMed ID: 830414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic characterization of hemostasis in thermal injury.
    Simon TL; Curreri PW; Harker LA
    J Lab Clin Med; 1977 Apr; 89(4):702-11. PubMed ID: 845474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of glycaemic control on fibrin network structure of type 2 diabetic subjects.
    Pieters M; Covic N; Loots du T; van der Westhuizen FH; van Zyl DG; Rheeder P; Jerling JC; Weisel JW
    Thromb Haemost; 2006 Nov; 96(5):623-9. PubMed ID: 17080220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinogen survival and fibrinopeptide A in acute leukemia.
    Castaman G; Galloni E; Dri AV; Rodeghiero F
    Haematologica; 1993; 78(6 Suppl 2):52-6. PubMed ID: 8039760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble fibrin complexes and fibrinogen heterogeneity in diabetes mellitus.
    Tsianos EB; Stathakis NE
    Thromb Haemost; 1980 Dec; 44(3):130-4. PubMed ID: 6162208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma thrombin clotting time and plasma fibrinogen in diabetes mellitus and atherosclerosis.
    Banerjee RN; Kumar V; Sahni AL
    Indian J Med Res; 1972 Oct; 60(10):1432-42. PubMed ID: 4661652
    [No Abstract]   [Full Text] [Related]  

  • 15. [Some indices of the blood coagulation system and thrombus-formation in patients with diabetes mellitus].
    Ivanova NA
    Kardiologiia; 1971 Aug; 11(8):121-5. PubMed ID: 5160867
    [No Abstract]   [Full Text] [Related]  

  • 16. In vivo behaviour of homologous urea-soluble 131I-fibrin and 125I-fibrinogen in rabbits: the effect of fibrinolysis inhibition.
    Müller-Berghaus G; Mahn I; Köveker G; Maul FD
    Br J Haematol; 1976 May; 33(1):61-79. PubMed ID: 1268091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of N-acetylcysteine on fibrin deposition in the rat lung due to intravascular coagulation.
    Wegener T; Wallin R; Saldeen T
    Ups J Med Sci; 1986; 91(1):45-52. PubMed ID: 3716022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute polycythemia increases the disappearance rate of clottable fibrinogen in the newborn dog.
    LeBlanc MH; Edwards JD
    Pediatr Res; 1986 Feb; 20(2):151-4. PubMed ID: 3945524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased thromboplastic potential in diabetes: a multifactorial phenomenon.
    Landgraf-Leurs MM; Ladik T; Smolka B; Bock T; Schramm W; Spannagl M; Landgraf R
    Klin Wochenschr; 1987 Jul; 65(13):600-6. PubMed ID: 3626428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinogen kinetics and protein turnover in obese non-diabetic males: effects of insulin.
    Tessari P; Cosma A; Vettore M; Millioni R; Puricelli L; Cogo P; Cecchet D; Carnielli V; Kiwanuka E
    Diabetes Metab Res Rev; 2010 Jan; 26(1):50-8. PubMed ID: 19943326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.